Gut Microbiota Composition for DNase Modulation and Barrier Function
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies fail to effectively modulate deoxyribonuclease (DNase) activity, leading to issues such as intestinal barrier dysfunction, neurodegenerative diseases, and various chronic conditions like diabetes and cancer, due to the formation of bacterial biofilms and DNA-protein complexes.
Innovation Solution
Compositions comprising magnesium and sodium cations, along with additives like ascorbic acid and plant extracts, are used to modulate DNase activity, preventing DNA-protein complex formation and maintaining gut barrier function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current technologies are used to modulate DNase activity, then existing treatment methods can be applied, but they fail to effectively prevent intestinal barrier dysfunction and neurodegenerative diseases
Solution Approach 1:
The patent changes the chemical parameters of the composition by specifying precise concentrations of magnesium cations (6.0-155.0 mg/l) and sodium cations (0.005-12.0 mg/l), along with controlled pH levels (6.0-7.5), to effectively modulate DNase activity and prevent harmful effects
Solution Approach 2:
The patent uses magnesium and sodium cations as intermediary substances that mediate between the composition and DNase activity, preventing direct harmful interactions while maintaining gut barrier function and reducing bacterial penetration
2Stability of the object's composition
If bacterial biofilms and DNA-protein complexes form, then natural gut processes occur, but they lead to intestinal barrier dysfunction and various chronic conditions
Solution Approach 1:
The patent converts the natural formation of DNA-protein complexes, which would normally be harmful, into a beneficial process by using magnesium and sodium cations to modulate DNase activity, thereby preventing pathological bacterial penetration while maintaining natural gut processes
3Ease of manufacture
If DNase activity is not effectively modulated, then existing compositions can be used, but they cannot prevent disease progression
Solution Approach 1:
The patent achieves effective disease prevention by optimizing specific parameters including magnesium cation concentration (6.0-155.0 mg/l), sodium cation concentration (0.005-12.0 mg/l), and pH (6.0-7.5), creating a composition that is both simple to manufacture and highly effective
Solution Approach 2:
The patent creates a composite composition combining multiple cations (magnesium and sodium) with water and optional additives, where the synergistic interaction of components provides enhanced disease prevention capability while maintaining manufacturing simplicity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compositions enhance DNase activity, reducing bacterial penetration, inhibiting neurodegenerative and oncological diseases, and improving metabolic health by enhancing gut barrier function and reducing excess weight.
Implementation Method 1
Compositions comprising magnesium and sodium cations, along with additives like ascorbic acid and plant extracts, are used to modulate DNase activity
Data Source
AI summary
The present invention provides compositions that modulate gut microbiota and/or the activity of deoxyribonucleases (e.g., in the gastrointestinal tract) and are useful in the treatment of diseases and disorders related to the activity of deoxyribonucleases including, for example, neurodegenerative, inflammatory, and metabolic diseases and cancer.